SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 131 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $159,000 | -23.6% | 8,854 | -49.8% | 0.00% | +100.0% |
| Q3 2017 | $208,000 | +12.4% | 17,635 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $185,000 | -4.6% | 17,635 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $194,000 | -18.8% | 17,635 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $239,000 | +23.8% | 17,635 | +12.2% | 0.00% | +100.0% |
| Q3 2016 | $193,000 | -3.5% | 15,713 | -14.0% | 0.00% | 0.0% |
| Q2 2016 | $200,000 | 0.0% | 18,274 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $200,000 | -36.7% | 18,274 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $316,000 | -12.9% | 18,274 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $363,000 | +38.5% | 18,274 | +14.5% | 0.00% | +50.0% |
| Q2 2015 | $262,000 | +10.5% | 15,953 | +4.9% | 0.00% | 0.0% |
| Q1 2015 | $237,000 | +9.2% | 15,208 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $217,000 | – | 15,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
| OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
| JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
| AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
| NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
| Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
| OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
| Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |